CVS Health Corporation (CVS)

[DiscoverGold]

Equities Analysts Set Expectations for CVS Health Co.'s Q1 2021 Earnings
By: MarketBeat | February 21, 2021

CVS Health Co. (NYSE:CVS) - Equities researchers at Jefferies Financial Group issued their Q1 2021 earnings per share (EPS) estimates for shares of CVS Health in a report issued on Wednesday, February 17th. Jefferies Financial Group analyst B. Tanquilut anticipates that the pharmacy operator will post earnings of $1.49 per share for the quarter. Jefferies Financial Group has a "Buy" rating and a $90.00 price objective on the stock. Jefferies Financial Group also issued estimates for CVS Health's Q2 2021 earnings at $2.02 EPS, Q3 2021 earnings at $2.09 EPS, Q4 2021 earnings at $1.93 EPS and FY2021 earnings at $7.53 EPS. CVS Health (NYSE:CVS) last posted its earnings results on Monday, February 15th. The pharmacy operator reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.06. CVS Health had a net margin of 2.99% and a return on equity of 15.60%. During the same period in the prior year, the firm posted $1.73 earnings per share.

CVS has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of CVS Health from $104.00 to $101.00 and set a "buy" rating for the company in a research report on Monday, November 9th. Cantor Fitzgerald reissued an "overweight" rating on shares of CVS Health in a research report on Monday, November 9th. Piper Sandler boosted their price objective on shares of CVS Health from $72.00 to $76.00 and gave the company an "overweight" rating in a research report on Wednesday, November 11th. Finally, SVB Leerink boosted their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a "market perform" rating in a research report on Monday, December 14th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. CVS Health presently has an average rating of "Buy" and a consensus price target of $82.08.

Read Full Story »»»

DiscoverGold